References
- Akay OM, Aras BD, Isiksoy S et al (2014). BCL2, BCL6, IGH, TP53, and MYC protein expression and gene rearrangements as prognostic markers in diffuse large B-cell lymphoma: a study of 44 Turkish patients. Cancer Genet, 207, 87-93. https://doi.org/10.1016/j.cancergen.2014.02.001
- Ali AE, Morgen EK, Geddie WR et al (2010). Classifying B-cell non-Hodgkin lymphoma by using MIB-1 proliferative index in fine-needle aspirates. Cancer Cytopathol, 118, 166-72. https://doi.org/10.1002/cncy.20075
- Bellas C, Garcia D, Vicente Y et al (2014). Immunohistochemical and molecular characteristics with prognostic significance in diffuse large B-celllymphzoma. PLoS One, 9, e98169. https://doi.org/10.1371/journal.pone.0098169
- Bhurgri Y, Pervez S, Bhurgri A et al (2005). Increasing incidence of non-Hodgkin's lymphoma in Karachi, 1995-2002. Asian Pac J Cancer Prev, 6, 364-9.
- Broyde A, Boycov O, Strenov Y et al (2009). Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma. Am J Hematol, 84, 338-43. https://doi.org/10.1002/ajh.21406
- Broyde A, Boycov O, Strenov Y et al (2009). Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma. Am J Hematol, 84, 338-43. https://doi.org/10.1002/ajh.21406
- Cook JR, Goldman B, Tubbs RR et al (2014). Clinical significance of MYC expression and/or “high-grade” morphology in non-Burkitt, diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative study. Am J Surg Pathol, 38, 494-501. https://doi.org/10.1097/PAS.0000000000000147
- Erlanson M, Casiano CA, Tan EM et al (1999). Immunohistochemical analysis of the proliferation associated nuclear antigen CENP-F in non-Hodgkin's lymphoma. Mod Pathol, 12, 69-74.
- Gaudio F, Giordano A, Perrone T et al (2011). High Ki67 index and bulky disease remain significant adverse prognostic factors in patients with diffuse large B cell lymphoma before and after the introduction of rituximab. Acta Haematol, 126, 44-51. https://doi.org/10.1159/000324206
- Gerdes J, Lemke H, Baisch H et al (1984). Cell cycle analysis of a cell proliferation- associated human nuclear antigen defined by monoclonal antibody Ki67. J Immunol, 133, 1710-1715
- Gerdes J, Schwab U, Lemke H, Stein H (1983). Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer, 31, 13-20 https://doi.org/10.1002/ijc.2910310104
- Gunia S, Kakies C, Erbersdobler A, Koch S, May M (2012). Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa. J Clin Pathol, 65, 715-20. https://doi.org/10.1136/jclinpath-2011-200532
- Hadzi-Pecova L, Petrusevska G, Stojanovic A (2007). Non-Hodgkin's lymphomas: immunologic prognostic studies. Prilozi, 28, 39-55.
- Haroon S, Hashmi AA, Khurshid A et al (2013). Ki67 index in breast cancer: correlation with other prognostic markers and potential in Pakistani patients. Asian Pac J Cancer Prev, 14, 4353-8. https://doi.org/10.7314/APJCP.2013.14.7.4353
- He X, Chen Z, Fu T et al (2014). Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis. BMC Cancer, 14, 153. https://doi.org/10.1186/1471-2407-14-153
- Ishtiaq S, Hassan U, Mushtaq S, Akhtar N (2013). Determination of frequency of Epstein-Barr virus in non-Hodgkin lymphomas using EBV latent membrane protein 1 (EBVLMP1) immunohistochemical staining. Asian Pac J Cancer Prev, 14, 3963-7. https://doi.org/10.7314/APJCP.2013.14.6.3963
- Jerkeman M, Anderson H, Dictor M, Kvaloy S, Akerman M (2004). Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study. Ann Hematol, 83, 414-9. https://doi.org/10.1007/s00277-004-0855-x
- Jung SH, Yang DH, Ahn JS et al (2014). Serum lactate dehydrogenase with a systemic inflammation score is useful for predicting response and survival in patients with newly diagnosed diffuse large b-cell lymphoma. Acta Haematol, 133, 10-17.
- Kalogeraki A, Tzardi M, Panagiotides I et al (1997). MIB1 (Ki-67) expression in non-Hodgkin's lymphomas. Anticancer Res, 17, 487-491.
- Li J, Hu R, Liao AJ et al (2011). Ki-67 proliferative index in non-Hodgkin's lymphoma and its clinical significance. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 19, 935-9.
- Li S, Feng X, Li T et al (2013). Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center. Am J Surg Pathol, 14, 14-23.
- Martin AR, Weisenburger DD, Chan WC et al (1995). Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood, 85, 3671-8.
- Niikura N, Iwamoto T, Masuda S et al (2012). Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer. Cancer Sci, 103, 1508-12. https://doi.org/10.1111/j.1349-7006.2012.02319.x
- Petit B, Chaury MP, Le Clorennec C et al (2005).Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expressionidentifies a better prognosis subgroup. Haematologica, 90, 200-6.
- Pinto AE, Cabecadas J, Nobrega SD, Mendonca E (2003). Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma. Diagn Cytopathol, 29, 194-9. https://doi.org/10.1002/dc.10298
- Rabenhorst SH, Burini RC, Schmitt FC (1996). Proliferating cell nuclear antigen (PCNA) in non-Hodgkin's lymphomas: correlation with Working Formulation and Kiel classification in formalin-fixed paraffin-embedded material. Pathology, 28, 12-16. https://doi.org/10.1080/00313029600169423
- Rosenwald A, Wright G, Wiestner A et al (2003). The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survivalin mantle cell lymphoma. Cancer Cell, 3, 185-97. https://doi.org/10.1016/S1535-6108(03)00028-X
- Salek D, Vesela P, Boudova L et al (2014). Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database. Leuk Lymphoma, 55, 802-10. https://doi.org/10.3109/10428194.2013.815349
- Schaffel R, Hedvat CV, Teruya-Feldstein J et al (2010). Prognostic impact of proliferative index determined by quantitative image analysis and the InternationalPrognostic Index in patients with mantle cell lymphoma. Ann Oncol, 21, 133-9. https://doi.org/10.1093/annonc/mdp495
- Swerdlow SH, Camp E, Harris NL et al (2008). WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. In World Health Organization Classification of Tumors, 4th ed. Lyon: International Agency for Research.
- Vaidya R, Witzig TE (2014). Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era. Ann Oncol. pii: mdu109.
- Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S (2006). Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol, 24, 2472-9. https://doi.org/10.1200/JCO.2005.03.6327
- Wu L, Wang T, Gui W, Lin H, Xie K (2014). Prognostic Significance of Serum Beta-2 Microglobulin in Patients with Non-Hodgkin Lymphoma. Oncology, 87, 40-47. https://doi.org/10.1159/000362670
- Zekri AR, Hassan ZK, Bahnassy AA et al (2013). Gene expression profiling of non-hodgkin lymphomas. Asian Pac J Cancer Prev, 14, 4393-8. https://doi.org/10.7314/APJCP.2013.14.7.4393
- Zhang ZX, Shen CF, Zou WH et al (2013). Exploration of molecular mechanisms of diffuse large B-cell lymphoma development using a microarray. Asian Pac J Cancer Prev, 14, 929-34. https://doi.org/10.7314/APJCP.2013.14.2.929
- Zhou D, Xie WZ, Hu KY et al (2013). Prognostic values of various clinical factors and genetic subtypes for diffuse large B-cell lymphoma patients: a retrospective analysis of 227 cases. Asian Pac J Cancer Prev, 4, 929-34. https://doi.org/10.7314/APJCP.2013.14.2.929
Cited by
- Diffuse large B cell lymphoma associated with chronic inflammation arising within atrial myxoma: aggressive histological features but indolent clinical behaviour vol.71, pp.6, 2017, https://doi.org/10.1111/his.13336